Literature DB >> 24266824

CYP2D6's functional status associated with the length of hospitalization stay in psychiatric patients: a twist in the tale or evidence that matters?

Jorge Duconge1, Carmen L Cadilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24266824      PMCID： PMC4109677          DOI： 10.2217/bmm.13.109

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  4 in total

1.  Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.

Authors:  Stefan Kropp; Ralf Lichtinghagen; Kathrin Winterstein; Jann Schlimme; Udo Schneider
Journal:  Clin Lab       Date:  2006       Impact factor: 1.138

2.  Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

Authors:  Robert S Epstein; Thomas P Moyer; Ronald E Aubert; Dennis J O Kane; Fang Xia; Robert R Verbrugge; Brian F Gage; J Russell Teagarden
Journal:  J Am Coll Cardiol       Date:  2010-04-08       Impact factor: 24.094

3.  Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?

Authors:  B Laika; S Leucht; S Heres; W Steimer
Journal:  Pharmacogenomics J       Date:  2009-05-19       Impact factor: 3.550

4.  Length of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorder.

Authors:  Gualberto Ruaño; Bonnie L Szarek; David Villagra; Krystyna Gorowski; Mohan Kocherla; Richard L Seip; John W Goethe; Harold I Schwartz
Journal:  Biomark Med       Date:  2013-06       Impact factor: 2.851
  4 in total
  1 in total

1.  CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series.

Authors:  Davide Seripa; Madia Lozupone; Giuseppe Miscio; Eleonora Stella; Maddalena La Montagna; Carolina Gravina; Maria Urbano; Lazzaro di Mauro; Antonio Daniele; Antonio Greco; Giancarlo Logroscino; Francesco Panza; Antonello Bellomo
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.